Doses of fezolinetant up to 900 mg have been tested in clinical studies in healthy women. At 900 mg, headache, nausea, and paraesthesia were observed.
In the case of overdose, the individual should be closely monitored, and supportive treatment should be considered based on signs and symptoms.
Other Services
Country
Account